Abnormal fibrin structure and inhibition of fibrinolysis in patients with multiple myeloma
- 31 July 1996
- journal article
- Published by Elsevier in Journal of Laboratory and Clinical Medicine
- Vol. 128 (1) , 83-88
- https://doi.org/10.1016/s0022-2143(96)90116-x
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Lupus anticoagulant associated syndrome in benign and malignant systemic disease — Analysis of ten observationsJournal of Molecular Medicine, 1987
- Albumin modulates lateral assembly of fibrin polymers: evidence of enhanced fine fibril formation and of unique synergism with fibrinogenBiochemistry, 1987
- Nonenzymatic glycosylation reduces the susceptibility of fibrin to degradation by plasminDiabetes, 1983
- Incomplete Fibrin Formation and Highly Elevated Factor XIII Activity in Multiple MyelomaScandinavian Journal of Haematology, 1981
- Mass–length ratio of fibrin fibers from gel permeation and light scatteringBiopolymers, 1977
- Analysis of a Fibrin Formation Abnormality in a Case of Multiple MyelomaScandinavian Journal of Haematology, 1975
- Abnormal Fibrin Ultrastructure, Polymerization, and Clot Retraction in Multiple Myeloma*British Journal of Haematology, 1970
- BLOOD COAGULATION AND FIBRINOLYSIS IN MULTIPLE MYELOMAOThe Lancet Healthy Longevity, 1967
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957
- Preparation and Properties of Serum and Plasma Proteins. VIII. The Conversion of Human Fibrinogen to Fibrin under Various Conditions1,2Journal of the American Chemical Society, 1947